Focus Diagnostics Home
 Home  About Focus Diagnostics  Employment  Contact Us
Test Listing New Tests Test Updates Certifications Client Services Account Setup Contact Us
 
Click the controls at right to expand & collapse the search function Open the search function Close the search function
Please select the first letter of the test you are interested in viewing or
click NEW for a complete listing of our newest assays.
Enter Test Name(s) / Code(s): Test Title Description Category Search:
 
All words must appear Any word can appear    
Reference Laboratory
Tests
 
40795
Q Fever (Coxiella burnetii) Antibodies (IgG, IgM) with Reflex to Titers print

Active Q Fever infections are characterized by a fourfold increase in serum IgG between acute and convalescent samples and/or the presence of IgM antibodies directed against phase II organisms. In chronic Q Fever the IgG and/or IgM response is most often directed against phase I organisms, resulting in phase I titers that are greater than phase II titers.

If a screen is positive the appropriate titer will be performed at an additional charge. Titers are not performed or reported if screens are negative. Coxiella burnetti IgA will no longer be performed if the IgG or IgM are positive.

This test is approved for New York patient testing.

IFA (Immunofluorescence Assay)
Screen: Negative
Titer: <1:16
1 mL serum
(minimum 0.2 mL)
Refrigerated
1 to 4 days
86638 x 4
(add 86638 per titer performed)
Positive
Negative
 
-193
Q Fever (See Coxiella burnetii) print

 
40800
Q Fever (Coxiella burnetii) IgG with Reflex to Titers print

Active Q fever infections are characterized by a four fold increase in Phase II IgG between acute and convalescent samples. In chronic Q fever, Phase I IgG and/or IgM titers are usually greater than Phase II titers. Past infection is usually associated with roughly equivalent Phase I and Phase II IgG titers. Diagnosis of acute Q fever based on a single IgG titer is difficult. Phase II IgG titer between 1:16 and 1:256 in the absence of Phase I IgG titers are not considered significant and may be seen in the healthy, asymptomatic population. If the screen is positive a titer will be performed at an additional charge.

This test is approved for New York patient testing.

IFA (Immunofluorescence Assay)
Screen: Negative
Titer: <1:16
0.5 mL serum
(minimum 0.2 mL)
Refrigerated
1 to 4 days
86638 x 2
(add 86638 if titer is performed)
Positive
Negative
 
40805
Q Fever (Coxiella burnetii) IgM with Reflex to Titers print

Active Q fever infections are characterized by the presence of Phase II IgM. In chronic Q fever, Phase I IgG and/or IgM titers are usually greater than Phase II titers. If the screen is positive a titer will be performed at an additional charge.

This test is approved for New York patient testing.

IFA (Immunofluorescence Assay)
Screen: Negative
Titer: <1:16
0.5 mL serum
(minimum 0.2 mL)
Refrigerated
1 to 4 days
86638 x 2
(add 86638 if titer is performed)
Positive
Negative
 
 
First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics


FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics’ Focus Diagnostics


Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.


Focus Diagnostics receives NYSDOH exemption for Diagnostic Immunology and Serology testing services


Focus Diagnostics Launches Laboratory Test for Chikungunya Virus


 
   
Back to top  
   
©2010 - Focus Diagnostics - All Rights Reserved - Site Revision ID: WEB.FOCUSDX.C3 - Privacy Policy - Site Map